Page last updated: 2024-09-03

gefitinib and Adenoma

gefitinib has been researched along with Adenoma in 7 studies

Research

Studies (7)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (14.29)29.6817
2010's6 (85.71)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Collard, TJ; Greenhough, A; Gupta, B; Legge, DN; Morgan, RG; Mortensson, E; Williams, AC1
Feelders, RA; Hofland, LJ; Lacroix, A; Newell-Price, J; Nieman, LK; Pivonello, R1
Hudish, TM; Karoor, V; Keith, RL; Le, M; Miller, YE; Mozer, AB1
Clarke, AR; Maughan, TS; Shaw, PH1
Wondisford, FE1
Ben-Shlomo, A; Bruyette, D; Cooper, O; Fukuoka, H; Mamelak, A; Melmed, S; Ren, SG1
Bissonnette, M; Cerda, S; Cohen, G; Dougherty, U; Fichera, A; Gong, C; Hart, J; Jagadeeswaran, S; Joseph, L; Khare, S; Little, N; Mustafi, R; Sehdev, A; Tallerico, M; Tretiakova, M; Turner, JR; Yuan, W1

Reviews

1 review(s) available for gefitinib and Adenoma

ArticleYear
Advances in the medical treatment of Cushing's syndrome.
    The lancet. Diabetes & endocrinology, 2019, Volume: 7, Issue:4

    Topics: ACTH Syndrome, Ectopic; ACTH-Secreting Pituitary Adenoma; Adenoma; Adrenal Gland Neoplasms; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Cabergoline; Cushing Syndrome; Dopamine Agonists; ErbB Receptors; Gefitinib; Hormones; Humans; Imidazoles; Isoquinolines; Molecular Targeted Therapy; Pituitary ACTH Hypersecretion; Pyrazoles; Pyridines; Receptors, Glucocorticoid; Roscovitine; Somatostatin; Temozolomide; Tretinoin

2019

Other Studies

6 other study(ies) available for gefitinib and Adenoma

ArticleYear
LGR5 expression is regulated by EGF in early colorectal adenomas and governs EGFR inhibitor sensitivity.
    British journal of cancer, 2018, 02-20, Volume: 118, Issue:4

    Topics: Adenoma; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Cell Survival; Colorectal Neoplasms; Disease Progression; Down-Regulation; Drug Synergism; Epidermal Growth Factor; Gefitinib; Gene Expression Regulation, Neoplastic; Humans; Protein Kinase Inhibitors; Receptors, G-Protein-Coupled; Wnt Signaling Pathway

2018
Chemoprevention of murine lung cancer by gefitinib in combination with prostacyclin synthase overexpression.
    Lung cancer (Amsterdam, Netherlands), 2010, Volume: 70, Issue:1

    Topics: Adenoma; Animals; Antineoplastic Agents; Cadherins; Cytochrome P-450 Enzyme System; Dinoprostone; Epoprostenol; ErbB Receptors; Female; Gefitinib; Intramolecular Oxidoreductases; Lung Neoplasms; Male; Mice; Mice, Transgenic; Protein Kinase Inhibitors; Quinazolines; Rats; Signal Transduction

2010
Dual inhibition of epidermal growth factor and insulin-like 1 growth factor receptors reduce intestinal adenoma burden in the Apc(min/+) mouse.
    British journal of cancer, 2011, Aug-23, Volume: 105, Issue:5

    Topics: Adenoma; Animals; Antineoplastic Combined Chemotherapy Protocols; Down-Regulation; Drug Evaluation, Preclinical; Drug Synergism; ErbB Receptors; Gefitinib; Genes, APC; Intestinal Neoplasms; Isoxazoles; Male; Mice; Mice, Inbred C57BL; Mice, Transgenic; Protein Kinase Inhibitors; Pyrimidines; Quinazolines; Receptor, IGF Type 1; Tumor Burden

2011
A new medical therapy for Cushing disease?
    The Journal of clinical investigation, 2011, Volume: 121, Issue:12

    Topics: ACTH-Secreting Pituitary Adenoma; Adenoma; Animals; ErbB Receptors; Gefitinib; Humans; Molecular Targeted Therapy; Protein Kinase Inhibitors; Quinazolines

2011
EGFR as a therapeutic target for human, canine, and mouse ACTH-secreting pituitary adenomas.
    The Journal of clinical investigation, 2011, Volume: 121, Issue:12

    Topics: ACTH-Secreting Pituitary Adenoma; Adenoma; Adrenocorticotropic Hormone; Animals; Cell Line, Tumor; Corticosterone; Dog Diseases; Dogs; Drug Screening Assays, Antitumor; ErbB Receptors; Gefitinib; Gene Expression Regulation, Neoplastic; Humans; Mice; Mice, Nude; Molecular Targeted Therapy; Neoplasm Transplantation; Pituitary ACTH Hypersecretion; Pro-Opiomelanocortin; Promoter Regions, Genetic; Protein Kinase Inhibitors; Quinazolines; Secretory Rate; Tumor Burden

2011
Epidermal growth factor receptor signaling is required for microadenoma formation in the mouse azoxymethane model of colonic carcinogenesis.
    Cancer research, 2007, Jan-15, Volume: 67, Issue:2

    Topics: Adenoma; Animals; Azoxymethane; beta Catenin; Carcinogens; Cell Transformation, Neoplastic; Colonic Neoplasms; Cyclin D1; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Disease Models, Animal; ErbB Receptors; Gefitinib; Genes, ras; Male; Mice; Mice, Inbred A; Mutation; Quinazolines; Signal Transduction; Up-Regulation

2007